Viewing Study NCT04588194


Ignite Creation Date: 2025-12-25 @ 1:34 AM
Ignite Modification Date: 2025-12-27 @ 11:44 PM
Study NCT ID: NCT04588194
Status: UNKNOWN
Last Update Posted: 2020-10-19
First Post: 2020-01-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Romiplostim, Rituximab and Dexamethasone as Frontline Treatment for Immune Thrombocytopenia
Sponsor: David Gomez Almaguer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module